CCNA2 and neoplasm: MAGE-A3, MAGE-A4, cyclin D, cyclin E, cyclin A and cyclin B mRNA expression levels in tumor samples categorized by Brigham and Women’s Hospital Tumor Staging System and tumor differentiation are shown in Fig 1.